Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2014 (2014), Article ID 724281, 7 pages
http://dx.doi.org/10.1155/2014/724281
Research Article

A Disease Modification Effect of APOE E4 on the Association between Urinary Albumin Excretion and Cognition in Korean Adults

1Department of Preventive Medicine, Chonnam National University Medical School, Gwangju, Republic of Korea
2Department of Preventive Medicine & Institute of Wonkwang Medical Science, Wonkwang University College of Medicine, Iksan, Jeonbuk, Republic of Korea
3Department of Preventive Medicine, Chungnam National University College of Medicine, Daejeon, Republic of Korea
4Department of Preventive Medicine, Seonam University College of Medicine, Namwon, Jeonbuk, Republic of Korea
5Center for Creative Biomedical Scientists, Chonnam National University, Gwangju, Republic of Korea
6Department of Neurology & Research Institute of Clinical Medicine, Chonbuk National University, Biomedical Research Institute of Chonbuk National University Hospital, San 2-20, Geumam-dong, Deokjin-gu, Jeonju, Jeonbuk 561-180, Republic of Korea

Received 30 June 2014; Accepted 10 September 2014; Published 30 October 2014

Academic Editor: Claudio Letizia

Copyright © 2014 Min-Ho Shin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Prince, R. Bryce, E. Albanese, A. Wimo, W. Ribeiro, and C. P. Ferri, “The global prevalence of dementia: a systematic review and metaanalysis,” Alzheimer's and Dementia, vol. 9, no. 1, pp. 63.e2–75.e2, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Venketasubramanian, S. Sahadevan, E. H. Kua, C. P. L. Chen, and T.-P. Ng, “Interethnic differences in dementia epidemiology: global and Asia-Pacific perspectives,” Dementia and Geriatric Cognitive Disorders, vol. 30, no. 6, pp. 492–498, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. H.-H. Parving, J. B. Lewis, M. Ravid, G. Remuzzi, and L. G. Hunsicker, “Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective,” Kidney International, vol. 69, no. 11, pp. 2057–2063, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. R. J. Glassock, “Is the presence of microalbuminuria a relevant marker of kidney disease?” Current Hypertension Reports, vol. 12, no. 5, pp. 364–368, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Mykkänen, S. M. Haffner, J. Kuusisto, K. Pyorälä, and M. Laakso, “Microalbuminuria precedes the development of NIDDM,” Diabetes, vol. 43, no. 4, pp. 552–557, 1994. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Jessani, A. S. Levey, N. Chaturvedi, and T. H. Jafar, “High normal levels of albuminuria and risk of hypertension in Indo-Asian population,” Nephrology Dialysis Transplantation, vol. 27, no. 3, pp. iii58–iii64, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. H. L. Hillege, V. Fidler, G. F. H. Diercks et al., “Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population,” Circulation, vol. 106, no. 14, pp. 1777–1782, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. H.-K. Kuo, L.-Y. Lin, and Y.-H. Yu, “Microalbuminuria is a negative correlate for cognitive function in older adults with peripheral arterial disease: results from the U.S. National Health and Nutrition Examination Survey 1999–2002,” Journal of Internal Medicine, vol. 262, no. 5, pp. 562–570, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. J. I. Barzilay, P. Gao, M. O'Donnell et al., “Albuminuria and decline in cognitive function: the ONTARGET/TRANSCEND studies,” Archives of Internal Medicine, vol. 171, no. 2, pp. 142–150, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. J. I. Barzilay, A. L. Fitzpatrick, J. Luchsinger et al., “Albuminuria and dementia in the elderly: a community study,” The American Journal of Kidney Diseases, vol. 52, no. 2, pp. 216–226, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Bertram, M. B. McQueen, K. Mullin, D. Blacker, and R. E. Tanzi, “Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database,” Nature Genetics, vol. 39, no. 1, pp. 17–23, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. S.-S. Kweon, M.-H. Shin, S.-K. Jeong et al., “Cohort profile: the Namwon Study and the Dong-gu Study,” International Journal of Epidemiology, vol. 43, no. 2, pp. 558–567, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. J. E. Hixson and D. T. Vernier, “Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI,” Journal of Lipid Research, vol. 31, no. 3, pp. 545–548, 1990. View at Google Scholar · View at Scopus
  14. M.-H. Shin, S.-S. Kweon, J.-S. Choi et al., “The effect of an APOE polymorphism on cognitive function depends on age,” Journal of Neurology, vol. 261, no. 1, pp. 66–72, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. S.-K. Jeong, K.-H. Cho, and J.-M. Kim, “The usefulness of the Korean version of modified Mini-Mental State Examination (K-mMMSE) for dementia screening in community dwelling elderly people,” BMC Public Health, vol. 4, article 31, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. M. J. Cho and K. H. Kim, “Use of the center for epidemiologic studies depression (CES-D) scale in Korea,” Journal of Nervous and Mental Disease, vol. 186, no. 5, pp. 304–310, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. A. S. Levey, J. P. Bosch, J. B. Lewis, T. Greene, N. Rogers, and D. Roth, “A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation,” Annals of Internal Medicine, vol. 130, no. 6, pp. 461–470, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Joosten, G. J. Izaks, J. P. J. Slaets et al., “Association of cognitive function with albuminuria and eGFR in the general population,” Clinical Journal of the American Society of Nephrology, vol. 6, no. 6, pp. 1400–1409, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. A. M. Murray, J. I. Barzilay, J. F. Lovato et al., “Biomarkers of renal function and cognitive impairment in patients with diabetes,” Diabetes Care, vol. 34, no. 8, pp. 1827–1832, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. M. K. Tamura, P. Muntner, V. Wadley et al., “Albuminuria, kidney function, and the incidence of cognitive impairment among adults in the United States,” The American Journal of Kidney Diseases, vol. 58, no. 5, pp. 756–763, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. I. Sajjad, F. Grodstein, J. H. Kang, G. C. Curhan, and J. Lin, “Kidney dysfunction and cognitive decline in women,” Clinical Journal of the American Society of Nephrology, vol. 7, no. 3, pp. 437–443, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Morishima-Kawashima, N. Oshima, H. Ogata et al., “Effect of apolipoprotein E allele ε4 on the initial phase of amyloid β-protein accumulation in the human brain,” The American Journal of Pathology, vol. 157, no. 6, pp. 2093–2099, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Wisniewski, E. M. Castaño, A. Golabek, T. Vogel, and B. Frangione, “Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro,” The American Journal of Pathology, vol. 145, no. 5, pp. 1030–1035, 1994. View at Google Scholar · View at Scopus
  24. E. M. Reiman, K. Chen, X. Liu et al., “Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 16, pp. 6820–6825, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. A. E. Roher, Y.-M. Kuo, C. Esh et al., “Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer's disease,” Molecular Medicine, vol. 9, no. 3-4, pp. 112–122, 2003. View at Google Scholar · View at Scopus
  26. M. Wada, H. Nagasawa, K. Kurita et al., “Microalbuminuria is a risk factor for cerebral small vessel disease in community-based elderly subjects,” Journal of the Neurological Sciences, vol. 255, no. 1-2, pp. 27–34, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. D. S. Knopman, T. H. Mosley Jr., K. R. Bailey, C. R. Jack Jr., G. L. Schwartz, and S. T. Turner, “Associations of microalbuminuria with brain atrophy and white matter hyperintensities in hypertensive sibships,” Journal of the Neurological Sciences, vol. 271, no. 1-2, pp. 53–60, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. D. E. Weiner, K. Bartolomei, T. Scott et al., “Albuminuria, cognitive functioning, and white matter hyperintensities in homebound elders,” The American Journal of Kidney Diseases, vol. 53, no. 3, pp. 438–447, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Iadecola, “Neurovascular regulation in the normal brain and in Alzheimer's disease,” Nature Reviews Neuroscience, vol. 5, no. 5, pp. 347–360, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. R. M. Crum, J. C. Anthony, S. S. Bassett, and M. F. Folstein, “Population-based norms for the mini-mental state examination by age and educational level,” Journal of the American Medical Association, vol. 269, no. 18, pp. 2386–2391, 1993. View at Publisher · View at Google Scholar · View at Scopus
  31. S.-K. Jeong, J.-M. Kim, S.-S. Kweon, M.-H. Shin, M.-W. Seo, and Y.-H. Kim, “Does arm length indicate cognitive and functional reserve?” International Journal of Geriatric Psychiatry, vol. 20, no. 5, pp. 406–412, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. M. R. Weir, “Microalbuminuria and cardiovascular disease,” Clinical Journal of the American Society of Nephrology, vol. 2, no. 3, pp. 581–590, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. S.-S. Kweon, M.-H. Shin, J.-S. Choi et al., “Prevalence of albuminuria and associated cardiovascular risk factors: a community cohort in Namwon City, Korea,” Diabetes Research and Clinical Practice, vol. 97, no. 3, pp. 492–498, 2012. View at Publisher · View at Google Scholar · View at Scopus